BACKGROUND: Post-traumatic depression (PTD) may be a result of several factors like secondary injury chemical cascades as well as psycho-social factors following traumatic brain injury (TBI). While the role of serotonin in the pathology and treatment of idiopathic major depression may be somewhat controversial, it is unclear what role serotonin may play in PTD following a TBI. OBJECTIVE: To assess serotonergic function and genetic risk for PTD development over 1 year following TBI. RESEARCH DESIGN: Examination of variation in the serotonin transporter gene [SLC6A4 (5-HTTLPR, rs25331, and a variable number of tandem repeats variant in Intron 2)] in 109 subjects with moderate-severe injury. Depression was assessed using the Patient Health Questionnaire (PHQ-9) at 6 and/or 12 months post-injury. MAIN OUTCOMES AND RESULTS: At 6 months post-injury, subjects with a history of pre-morbid mood disorders and 5-HTTLPR L-homozygotes were at greater risk for PTD. Contrary to major depression, subjects without pre-morbid mood disorders (n = 80) and S-carriers were 2.803-times less likely to be depressed compared to L-homozygotes. At 12 months post-injury, LG-carriers were also less likely to experience PTD. Temporal analysis also showed 5-HTTLPR associations in PTD development across recovery. CONCLUSIONS: This study suggests a unique injury- and temporally-specific interaction between TBI and genetic risk for depression.
BACKGROUND: Post-traumatic depression (PTD) may be a result of several factors like secondary injury chemical cascades as well as psycho-social factors following traumatic brain injury (TBI). While the role of serotonin in the pathology and treatment of idiopathic major depression may be somewhat controversial, it is unclear what role serotonin may play in PTD following a TBI. OBJECTIVE: To assess serotonergic function and genetic risk for PTD development over 1 year following TBI. RESEARCH DESIGN: Examination of variation in the serotonin transporter gene [SLC6A4 (5-HTTLPR, rs25331, and a variable number of tandem repeats variant in Intron 2)] in 109 subjects with moderate-severe injury. Depression was assessed using the Patient Health Questionnaire (PHQ-9) at 6 and/or 12 months post-injury. MAIN OUTCOMES AND RESULTS: At 6 months post-injury, subjects with a history of pre-morbid mood disorders and 5-HTTLPR L-homozygotes were at greater risk for PTD. Contrary to major depression, subjects without pre-morbid mood disorders (n = 80) and S-carriers were 2.803-times less likely to be depressed compared to L-homozygotes. At 12 months post-injury, LG-carriers were also less likely to experience PTD. Temporal analysis also showed 5-HTTLPR associations in PTD development across recovery. CONCLUSIONS: This study suggests a unique injury- and temporally-specific interaction between TBI and genetic risk for depression.
Authors: Michelle D Failla; John M Myrga; Joseph H Ricker; C Edward Dixon; Yvette P Conley; Amy K Wagner Journal: J Head Trauma Rehabil Date: 2015 Nov-Dec Impact factor: 2.710
Authors: Michelle D Failla; Raj G Kumar; Andrew B Peitzman; Yvette P Conley; Robert E Ferrell; Amy K Wagner Journal: Neurorehabil Neural Repair Date: 2014-07-24 Impact factor: 3.919
Authors: Solomon M Adams; Yvette P Conley; Amy K Wagner; Ruchira M Jha; Robert Sb Clark; Samuel M Poloyac; Patrick M Kochanek; Philip E Empey Journal: Pharmacogenomics Date: 2017-10-04 Impact factor: 2.533
Authors: Michelle D Failla; Shannon B Juengst; Kristin M Graham; Patricia M Arenth; Amy K Wagner Journal: J Head Trauma Rehabil Date: 2016 Nov/Dec Impact factor: 2.710
Authors: Steven M Markos; Michelle D Failla; Anne C Ritter; C Edward Dixon; Yvette P Conley; Joseph H Ricker; Patricia M Arenth; Shannon B Juengst; Amy K Wagner Journal: J Head Trauma Rehabil Date: 2017 Mar/Apr Impact factor: 2.710